Evidence map›Paper›PMID 34648589›Full record

ArticlePloS one2021

Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya.

Elzette Rousseau, Ariana W K Katz, Shannon O'Rourke, Linda-Gail Bekker, Sinead Delany-Moretlwe, Elizabeth Bukusi, Danielle Travill, Victor Omollo, Jennifer F Morton, Gabrielle O'Malley and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 135 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Elzette RousseauDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-6487-6736
Ariana W K KatzRTI International, Women's Global Health Imperative (WGHI), Berkeley, CA, United States of America.
Shannon O'RourkeRTI International, Women's Global Health Imperative (WGHI), Berkeley, CA, United States of America.
Linda-Gail BekkerDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-0755-4386
Sinead Delany-MoretlweWits RHI, University of the Witwatersrand, Johannesburg, South Africa.
Elizabeth BukusiKenya Medical Research Institute, Kisumu, Kenya.
Danielle TravillWits RHI, University of the Witwatersrand, Johannesburg, South Africa.
Victor OmolloKenya Medical Research Institute, Kisumu, Kenya.
Jennifer F MortonInternational Clinical Research Center, University of Washington, Seattle, WA, United States of America.
Gabrielle O'MalleyInternational Clinical Research Center, University of Washington, Seattle, WA, United States of America.
Jessica E HabererHarvard Medical School, Harvard University, Boston, MA, United States of America.ORCID 0000-0001-5845-3190
Renee HeffronInternational Clinical Research Center, University of Washington, Seattle, WA, United States of America.
Rachel JohnsonInternational Clinical Research Center, University of Washington, Seattle, WA, United States of America.
Connie CelumInternational Clinical Research Center, University of Washington, Seattle, WA, United States of America.
Jared M BaetenInternational Clinical Research Center, University of Washington, Seattle, WA, United States of America.
Ariane van der StratenCentre for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco, CA, United States of America.
University of Washington · USDesmond Tutu HIV Foundation · ZAKenya Medical Research Institute · KERTI International · USUniversity of the Witwatersrand · ZAHarvard University · USUniversity of California, San Francisco · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
NIAID NIH HHS P30 AI027757NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

Successful scale-up of PrEP for HIV prevention in African adolescent girls and young women (AGYW) requires integration of PrEP into young women's everyday lives. We conducted interviews and focus group discussions with 137 AGYW PrEP users aged 16-25 from South Africa and Kenya. Individual and relational enablers and disablers were explored at key moments during their PrEP-user journey from awareness, initiation and early use through persistence, including PrEP pauses, restarts, and discontinuation. PrEP uptake was facilitated when offered as part of an integrated sexual reproductive health service, but hampered by low awareness, stigma and misconceptions about PrEP in the community. Daily pill-taking was challenging for AGYW due to individual, relational and structural factors and PrEP interruptions (intended or unintended) were described as part of AGYW's PrEP-user journey. Disclosure, social support, adolescent-friendly health counseling, and convenient access to PrEP were reported as key enablers for PrEP persistence.

Indexed as

Pre-Exposure ProphylaxisAdolescentAnti-HIV AgentsDisclosureFemaleHIV InfectionsHumansImplementation ScienceKenyaPsychology, AdolescentSocial StigmaSocial SupportSouth AfricaWomenYoung AdultAnti-HIV Agents

Identifiers

PMID34648589
PMCPMC8516266
OpenAlexW3205987343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.